Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers

Paul L. Schaefer, Randolph S. Marks, Michelle R. Mahoney, Jeff A. Sloan, Mitchell D. Bauman, Henry D. Tazelaar, John W. Kugler, James A. Mailliard, Larry P. Ebbert, Martin Wiesenfeld

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers'. Together they form a unique fingerprint.

Medicine & Life Sciences